BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 28425173)

  • 21. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.
    Pease C; Pope JE; Truong D; Bombardier C; Widdifield J; Thorne JC; Paul Haraoui B; Psaradellis E; Sampalis J; Bonner A
    Semin Arthritis Rheum; 2011 Aug; 41(1):81-9. PubMed ID: 21168187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of and outcomes following orthopaedic joint surgery in patients with early rheumatoid arthritis followed for 20 years.
    Gwinnutt JM; Symmons DPM; MacGregor AJ; Chipping JR; Lapraik C; Marshall T; Lunt M; Verstappen SMM
    Rheumatology (Oxford); 2017 Sep; 56(9):1510-1517. PubMed ID: 28510734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
    Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
    Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes.
    Bechman K; Tweehuysen L; Garrood T; Scott DL; Cope AP; Galloway JB; Ma MHY
    J Rheumatol; 2018 Nov; 45(11):1515-1521. PubMed ID: 30173149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Vitamin D Deficiency and Disease Activity, Disability, and Radiographic Progression in Early Rheumatoid Arthritis: The ESPOIR Cohort.
    Mouterde G; Gamon E; Rincheval N; Lukas C; Seror R; Berenbaum F; Dupuy AM; Daien C; Daurès JP; Combe B
    J Rheumatol; 2020 Nov; 47(11):1624-1628. PubMed ID: 31839594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register.
    Cook MJ; Diffin J; Scirè CA; Lunt M; MacGregor AJ; Symmons DP; Verstappen SM
    Rheumatology (Oxford); 2016 Sep; 55(9):1601-9. PubMed ID: 27220594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Databases of patients with early rheumatoid arthritis in the USA.
    Sokka T; Willoughby J; Yazici Y; Pincus T
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S146-53. PubMed ID: 14969067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health Assessment Questionnaire at One Year Predicts All-Cause Mortality in Patients With Early Rheumatoid Arthritis.
    Fatima S; Schieir O; Valois MF; Bartlett SJ; Bessette L; Boire G; Hazlewood G; Hitchon C; Keystone EC; Tin D; Thorne C; Bykerk VP; Pope JE;
    Arthritis Rheumatol; 2021 Feb; 73(2):197-202. PubMed ID: 32892510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome.
    van Tuyl LH; Britsemmer K; Wells GA; Smolen JS; Zhang B; Funovits J; van Schaardenburg D; Felson D; Boers M
    Ann Rheum Dis; 2012 Jan; 71(1):33-7. PubMed ID: 21953347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicentre observational study comparing patient reported outcomes to assess reliability of swollen and tender joint assessments and response to certolizumab treatment as compared to clinician assessments in rheumatoid arthritis.
    Inderjeeth CA; Inderjeeth AJ; Raymond WD
    Int J Rheum Dis; 2019 Jan; 22(1):73-80. PubMed ID: 30187688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simplified disease activity index for rheumatoid arthritis for use in clinical practice.
    Smolen JS; Breedveld FC; Schiff MH; Kalden JR; Emery P; Eberl G; van Riel PL; Tugwell P
    Rheumatology (Oxford); 2003 Feb; 42(2):244-57. PubMed ID: 12595618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative.
    Ruban TN; Jacob B; Pope JE; Keystone EC; Bombardier C; Kuriya B
    Clin Rheumatol; 2016 Mar; 35(3):759-63. PubMed ID: 26245721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Have the 10-year outcomes of patients with early inflammatory arthritis improved in the new millennium compared with the decade before? Results from the Norfolk Arthritis Register.
    Gwinnutt JM; Symmons DPM; MacGregor AJ; Chipping JR; Marshall T; Lunt M; Verstappen SMM
    Ann Rheum Dis; 2018 Jun; 77(6):848-854. PubMed ID: 29475855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.
    Schiff MH; Yu EB; Weinblatt ME; Moreland LW; Genovese MC; White B; Singh A; Chon Y; Woolley JM
    Drugs Aging; 2006; 23(2):167-78. PubMed ID: 16536638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-reported 28 swollen and tender joint counts accurately represent RA disease activity and can be used to assess therapy responses at the group level.
    Riazzoli J; Nilsson JÅ; Teleman A; Petersson IF; Rantapää-Dahlqvist S; Jacobsson LT; van Vollenhoven RF
    Rheumatology (Oxford); 2010 Nov; 49(11):2098-103. PubMed ID: 20615918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheumatoid arthritis patients with low baseline Health Assessment Questionnaire scores have a risk of functional disability progression: a post hoc analysis of a nationwide longitudinal cohort in Japan.
    Sumiyoshi R; Hidaka T; Koga T; Okada A; Fukuda T; Ishii T; Ueki Y; Kodera T; Nakashima M; Takahashi Y; Honda S; Horai Y; Watanabe R; Okuno H; Aramaki T; Izumiyama T; Takai O; Miyashita T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Eguchi K; Kawakami A;
    Clin Exp Rheumatol; 2020; 38(6):1096-1101. PubMed ID: 32896260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study.
    Innala L; Berglin E; Möller B; Ljung L; Smedby T; Södergren A; Magnusson S; Rantapää-Dahlqvist S; Wållberg-Jonsson S
    Arthritis Res Ther; 2014 Apr; 16(2):R94. PubMed ID: 24731866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
    Gordon P; West J; Jones H; Gibson T
    J Rheumatol; 2001 Nov; 28(11):2409-15. PubMed ID: 11708411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritis.
    Weng HH; Ranganath VK; Khanna D; Oh M; Furst DE; Park GS; Elashoff DA; Sharp JT; Gold RH; Peter JB; Paulus HE;
    J Rheumatol; 2010 Mar; 37(3):550-7. PubMed ID: 20110517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the disparity between inflammation and disability in the 10-year outcomes of people with rheumatoid arthritis.
    Gwinnutt JM; Norton S; Hyrich KL; Lunt M; Combe B; Rincheval N; Ruyssen-Witrand A; Fautrel B; McWilliams DF; Walsh DA; Nikiphorou E; Kiely PDW; Young A; Chipping JR; MacGregor A; Verstappen SMM
    Rheumatology (Oxford); 2022 Nov; 61(12):4687-4701. PubMed ID: 35274696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.